| Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (NCT05407636) | AbbVie | 2022-01-13 |
| the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration (NCT07375901) | The Filatov Institute of Eye Diseases and Tissue Therapy | 2021-03-25 |
| Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression (NCT04739319) | Center for Eye Research Australia | 2021-02-02 |
| Image Biomarkers for Progression of AMD (NCT04537143) | Doheny Image Reading Center | 2021-01-01 |
| Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (NCT04704921) | AbbVie | 2020-12-29 |
| Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration. (NCT05056025) | Institut de la Macula y la Retina | 2020-12-02 |
| Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD (NCT04177069) | VISUfarma SpA | 2019-12-11 |
| Retinal Imaging Using NOTAL-OCT V3.0 (NCT04078672) | Notal Vision Ltd. | 2019-12-02 |
| Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners (NCT03893474) | Moorfields Eye Hospital NHS Foundation Trust | 2019-09-30 |
| Retinal Imaging Using NOTAL-OCT V2.5 (NCT03600519) | Notal Vision Ltd. | 2018-07-22 |
| TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects (NCT03675880) | Lee's Pharmaceutical Limited | 2018-06-15 |
| Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On (NCT03367767) | National Eye Institute (NEI) | 2018-05-23 |
| Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration (NCT03372746) | National Eye Institute (NEI) | 2018-05-23 |
| Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation (NCT03478865) | National Eye Institute (NEI) | 2018-04-20 |
| CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) (NCT03803631) | Centre Hospitalier Intercommunal Creteil | 2018-04-04 |
| The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD (NCT03461393) | University of Applied Sciences Upper Austria | 2018-04-01 |
| Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan (NCT03324542) | Changhua Christian Hospital | 2017-04-03 |
| Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation (NCT02868424) | The First Affiliated Hospital with Nanjing Medical University | 2016-02-13 |
| Resveratrol for Exudative Age-Related Macular Degeneration (NCT02625376) | Poitiers University Hospital | 2015-08-06 |
| X-82 to Treat Age-related Macular Degeneration (NCT02348359) | Tyrogenex | 2015-03-16 |
| Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort (NCT07424235) | IRCCS Ospedale San Raffaele | 2015-01-01 |
| Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198 (NCT02226835) | National Eye Institute (NEI) | 2014-08-13 |
| Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study (NCT01915238) | National Eye Institute (NEI) | 2013-07-16 |
| AMD Phenotype and Genotype Study (NCT01778491) | National Eye Institute (NEI) | 2012-11-05 |
| Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) (NCT01632527) | StemCells, Inc. | 2012-06-01 |
| Cell Collection to Study Eye Diseases (NCT01432847) | National Eye Institute (NEI) | 2011-09-07 |
| Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) (NCT01339949) | Oraya Therapeutics, Inc. | 2011-06-01 |
| Post-Approval Study of the Implantable Miniature Telescope (NCT01757132) | VisionCare, Inc. | 2010-08-01 |
| INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (NCT01016873) | Oraya Therapeutics, Inc. | 2009-11-01 |
| Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort) (NCT01766596) | Centre Hospitalier Universitaire Dijon | 2009-10-01 |
| Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation (NCT00971464) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2009-09-01 |
| Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (NCT00726466) | Vitreous -Retina- Macula Consultants of New York | 2008-03-01 |
| OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration (NCT00306488) | National Institutes of Health Clinical Center (CC) | 2006-03-01 |
| Anecortave Acetate Risk-Reduction Trial (AART) (NCT00333216) | Alcon Research | 2005-05-01 |
| Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration (NCT01570790) | Johns Hopkins University | 2003-05-01 |
| Anecortave Acetate Versus Placebo in AMD Patients Following PDT (NCT00346866) | Alcon Research | 2000-05-01 |
| A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration (NCT00346957) | Alcon Research | 1999-04-01 |